{"name":"Glenn J. Hanna","slug":"glenn-j-hanna","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"CB-103","genericName":"CB-103","slug":"cb-103","indication":"Other","status":"phase_2"},{"name":"NAI","genericName":"NAI","slug":"nai","indication":"Treatment of acute gastroenteritis caused by norovirus","status":"marketed"}]}],"pipeline":[{"name":"CB-103","genericName":"CB-103","slug":"cb-103","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"NAI","genericName":"NAI","slug":"nai","phase":"marketed","mechanism":"NAI is an antiviral medication that inhibits the replication of the norovirus.","indications":["Treatment of acute gastroenteritis caused by norovirus"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOQU1YUmtWOGp3ak9XeVpESE45SWxfZHlTWHVYSWI1WlRuN21LQWN6NDBuZ3AwWUdocmlIdm0xMnNtY1l5VlBaTHFiY29sRjFUWVM5Umd0Mk4tLWhyTEtaMnhJQlNXNUJQLU5UdGstSUJiRTBlcGQ4ZV9fVUZoa2RtOGZPZ19DRTJFLXFpb0JWU1NidWhwM0N4NmVvSk5uZ093MGNmZU9VSQ?oc=5","date":"2024-04-25","type":"pipeline","source":"ascopost.com","summary":"Novel MDM2 Inhibitor Shows Activity in Salivary Gland Cancers - ascopost.com","headline":"Novel MDM2 Inhibitor Shows Activity in Salivary Gland Cancers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxPYnAwQV8wSHZEOTd2WXVreWMyZWl6eWNDdVRHcnVlYWx0cXdxQjRBeDVETlY0bEsyUE1YSm94M1d0Q3R2ZE43ak5VeHZKREFUa2V4R0p0YXhfRVVDNGRMTF9KT0h4OEVDM1ZMYmpMVVB3Y29hN2xnSmxtRnR6VXltQjRHWW41eV8tLU8wLUZFTTEydFBPVTc1Mm1WNWRqNEhzRkV3anljcWNPWE00Z3hkNnFmUGJtNkU0MzBvOWw1R3NmS3JRbHkyWFdrQUFWeGZBYmY3QVR3?oc=5","date":"2024-03-25","type":"pipeline","source":"ascopost.com","summary":"Lenvatinib Plus Pembrolizumab Fails to Improve Overall Survival in Recurrent or Metastatic Head and Neck Cancer - ascopost.com","headline":"Lenvatinib Plus Pembrolizumab Fails to Improve Overall Survival in Recurrent or Metastatic Head and Neck Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTE84Vm5rTDZaV2NfbXlGQ0hpR3NpWDhlSG5GbXlTTkJUam9lT3daNldiT3lLNHZLVjdLNV8zYXAzQ2lBeGRHZjJKQl9DeEUweVphUkNXM3U0MjU5SG40dGpxbV96Wm95VmtmYjZMcW5SMmNTekk?oc=5","date":"2024-02-13","type":"pipeline","source":"MedPage Today","summary":"Immunotherapy May Hold Promise for Skin Cancers After Kidney Transplant - MedPage Today","headline":"Immunotherapy May Hold Promise for Skin Cancers After Kidney Transplant","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE93dXFUR0RkOS1xSGpsUV9pWU9MVFdIZkstQWJVZURhQjNhNEFWLWxKZXo0a1BGX1lJcmY0dGJKUGZtVFVSQ2hDd0pRc1dza3BXTDM1VXl6elBWcUNraHFmN2g2SWduZDNlbXg0RHdZMXRwYjA5c3FBZHN3?oc=5","date":"2023-07-25","type":"pipeline","source":"acsjournals.onlinelibrary.wiley.com","summary":"The evolving landscape of salivary gland tumors - acsjournals.onlinelibrary.wiley.com","headline":"The evolving landscape of salivary gland tumors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxPaGVObTN1emlyUGRHbVl2bkdOU3RSVk1zcU41MUVmUDBvYVB4eWhUQmM2T2djLVFTLXNxbUxCRXlOdmxwNXNZQlZiVk9nbFZ6azB3eVFqT3hQY0VBQ3FJZEhGTE1OcG1uaWQ1SHZGU1lHZE9mWm83dnFyQjF1SFNRZFZLdVk4cl9zLVRzUXhIOGpoa0N6RFFyS2NmaWZ2M2UwX2lkZDgzcDVZZmxiLWEtLWRmN0pPTHN2Zlo5S1Z1RVNEMzZNOUJVSmhXRElFWUlWTjVuQU55Q21QcElK?oc=5","date":"2022-02-25","type":"pipeline","source":"Healio","summary":"Tumor tissue modified viral-HPV DNA test predicts HPV-driven oropharynx cancer recurrence - Healio","headline":"Tumor tissue modified viral-HPV DNA test predicts HPV-driven oropharynx cancer recurrence","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9XZGY3TjhTclc2UlI1cWJVN19VTEJKaE52ZjktbFVxYmN2SWltTW5WVFZtV3JTMVI2WmtEZDRrd1hyb3JOcTMzZnMxV09ESlRlVHQtYzJTVE1VRVdBRm1N?oc=5","date":"2020-09-01","type":"pipeline","source":"nature.com","summary":"Real-world outcomes treating patients with advanced cutaneous squamous cell carcinoma with immune checkpoint inhibitors (CPI) | British Journal of Cancer - nature.com","headline":"Real-world outcomes treating patients with advanced cutaneous squamous cell carcinoma with immune checkpoint inhibitors ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE9WUUotZm90M2NLVEg1LVFCYnpLbkhlbElDbDFjVFI2Y083cFI0QzgxV0djWHlCWElETmpWazQ2S0FzSnZGc1BXdkhnd0Y4VHJTLUtJTk5aUTVMancyV2tleDBWZUtQYXFQbERrSkU4eldFaE9RNHpNQjB4MA?oc=5","date":"2020-06-18","type":"pipeline","source":"acsjournals.onlinelibrary.wiley.com","summary":"Tipifarnib in recurrent, metastatic HRAS‐mutant salivary gland cancer - Hanna - 2020 - Cancer - acsjournals.onlinelibrary.wiley.com","headline":"Tipifarnib in recurrent, metastatic HRAS‐mutant salivary gland cancer - Hanna - 2020 - Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUEZLdDhZNWowRDk4SEt4QXMwbk5rNWNJZ2ZqakF2cUtHRjdqdy1JQjV0NlVSQ0N5RDU5T05pWEJwbXdQNkpiVVFZWllDUjgtX3pETFJRV000YUlXMHV6U3BvNktiQU9NSGZzRGxRb2VEWDB1ZlZCQWwzWlE0di1LRjF0dC0wNWRONkd2dnAxNnNwLVd5cjYxUFEzaHRrRURIMWpQWUhrdDV6UQ?oc=5","date":"2019-07-25","type":"pipeline","source":"ascopost.com","summary":"ASCO, Conquer Cancer Congratulate 2019 Grant and Award Recipients - ascopost.com","headline":"ASCO, Conquer Cancer Congratulate 2019 Grant and Award Recipients","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":1,"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}